Dr. Lai Wang
Equibles does not estimate personal net worth.
Get an email with a short summary when BeOne Medicines Ltd. publishes a filing, an earnings call transcript or a press release.
Get ONC alertsAbout Dr. Lai Wang
BeOne Medicines Ltd. reported in an 8-K filed December 18, 2025 that Dr. Lai Wang was appointed President, Global Head of Research and Development, effective December 17, 2025. BeOne Medicines Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BeOne Medicines Ltd. includes Mr. John V. Oyler (CEO and Board Member), John V. Oyler (Chairman), Mr. Aaron Rosenberg (CFO) and 7 others.
“On December 17, 2025, BeOne Medicines Ltd. (the “Company”) appointed Dr. Lai Wang to serve as President, Global Head of Research and Development of the Company.”
Affiliation history
-
BeOne Medicines Ltd. (ONC)
Proxy statement
CurrentStart not stated–present
Last confirmed April 28, 2026
Company network
Leadership on record at BeOne Medicines Ltd.
- Mr. John V. Oyler CEO, Board Member
- John V. Oyler Chairman
- Mr. Aaron Rosenberg CFO
- Dr. Xiaobin Wu COO
- Mr. Chan Lee General Counsel
- Titus Ball Chief Accounting Officer
- Alessandro Riva, M.D. Board Member
- Charles L. Sawyers Board Member
- Corazon (Corsee) D. Sanders Board Member
- Corsee Sanders, Ph.D. Board Member